Trial Profile
A Randomized, Double-blind, Multi-center, Active Controlled, Parallel-designed, Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Youths Above 16 Years or Adults
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Mar 2020
Price :
$35
*
At a glance
- Drugs BR-8003 (Primary) ; Hepatitis A vaccine inactivated
- Indications Hepatitis A
- Focus Pharmacodynamics; Registrational
- Acronyms VITHA-A
- Sponsors Boryung Pharmaceutical
- 19 Mar 2020 Status changed from active, no longer recruiting to completed.
- 07 Sep 2018 New trial record